Research ArticleOncology
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen and Penelope Ward
Journal of Nuclear Medicine October 2017, 58 (10) 1596-1602; DOI: https://doi.org/10.2967/jnumed.116.188375
Matthew P. Miller
1Blue Earth Diagnostics (BED), Oxford, United Kingdom
Lale Kostakoglu
2Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
Daniel Pryma
3Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Jian Qin Yu
4Fox Chase Cancer Center, Philadelphia, Pennsylvania
Albert Chau
1Blue Earth Diagnostics (BED), Oxford, United Kingdom
Eric Perlman
5American College of Radiology, Philadelphia, Pennsylvania; and
Bonnie Clarke
6Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network, Reston, Virginia
Donald Rosen
5American College of Radiology, Philadelphia, Pennsylvania; and
Penelope Ward
1Blue Earth Diagnostics (BED), Oxford, United Kingdom

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 10
October 1, 2017
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen, Penelope Ward
Journal of Nuclear Medicine Oct 2017, 58 (10) 1596-1602; DOI: 10.2967/jnumed.116.188375
Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Matthew P. Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen, Penelope Ward
Journal of Nuclear Medicine Oct 2017, 58 (10) 1596-1602; DOI: 10.2967/jnumed.116.188375